Empagliflozin in Pulmonary Arterial Hypertension

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions

Idiopathic Pulmonary Arterial Hypertension

Interventions

DRUG

Empagliflozin 10 MG

10 mg once daily empagliflozin oral tablets for 12 weeks

Trial Locations (1)

Amsterdam UMC, location Vumc, Amsterdam

All Listed Sponsors

lead

Amsterdam UMC, location VUmc

OTHER